MMCTS
HOME HELP FEEDBACK SUBSCRIPTIONS SEARCH

MMCTS (July 24, 2009). doi:10.1510/mmcts.2006.002378
Copyright © 2009 European Association for Cardio-thoracic Surgery


This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Podcast
Right arrow Alert me when this content is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this publication
Right arrow Alert me when new content is published
Right arrow Download to citation manager
Right arrow Author home page(s):
Alexander M. Fabricius
Timothy J. Jones
John G. Wright
David J. Barron
William J. Brawn
Right arrow Alert me when related articles are published
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fabricius, A. M.
Right arrow Articles by Brawn, W. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fabricius, A. M.
Right arrow Articles by Brawn, W. J.
Related Collections
Right arrow Single ventricle
 

Procedure


Surgical management of hypoplastic left heart syndrome at the Birmingham Children's Hospital

Alexander M. Fabricius*, Timothy J. Jones, John Stickley, Oliver Stümper, Ashish Chikermane, Tarak Desai, Paul Miller, Rami Dhillon, Joseph V. de Giovanni, John G. Wright, David J. Barron and William J. Brawn

Birmingham Children's Hospital, Cardiac Surgery, Birmingham, B4 6NH, UK

* Corresponding author: Tel.: +44-121-333 9435. almafa{at}web.de


    Summary
 Top
 Summary
 Introduction
 Surgical techniques
 Results
 Discussion
 Acknowledgements
 References
 
Currently, a three-stage surgical palliation remains the treatment of choice at Birmingham Children's Hospital. After initial introduction of the classical Norwood with pulmonary blood flow provided by a modified Blalock–Taussig shunt, a right ventricular to right pulmonary artery conduit at stage 1 Norwood palliation is now used in most cases, a bi-directional ‘Glenn’ shunt at second stage and an extra-cardiac Fontan completion at third stage. Mortality and morbidity has improved after modification of the technique. Thirty-day mortality was 32.4% (79/244) for the ‘classical’ Norwood procedure, 25.0% (7/28) for the left-sided RV-PA conduit and 12.7% (22/173) for the right-sided RV-PA conduit. Interstage mortality was 8.6% (21/244) for the ‘classical’ Norwood procedure, 14.3% (4/28) for the left and 10.1% (15/148) for right-sided RV-PA conduit. After stage II, 30-day mortality was 3.0% (10/335) for all groups. Stage III 30-day mortality was 0.9% (1/115) for all groups.

Key Words: CP shunt • Fontan procedure • Hypoplastic left heart syndrome (HLHS) • Left ventricular hypoplasia • Norwood procedure


    Introduction
 Top
 Summary
 Introduction
 Surgical techniques
 Results
 Discussion
 Acknowledgements
 References
 
The term hypoplastic left heart syndrome (HLHS) was introduced by Noonan and Nadas in 1958 [1]. Its prevalence is about 0.16–0.26 of 1000 live births of neonates in whom heart disease is diagnosed in the first year of life [2]. Without surgical intervention, HLHS is fatal and can account for 25% of cardiac deaths in the first week of life.

Morphology
Hypoplastic left heart syndrome refers to a congenital cardiac anomaly characterized by normal segmentation of the heart, hypoplasia or absence of the left ventricle with marked hypoplasia of the ascending aorta. The aortic and mitral valve may be stenotic or atretic. Aortic atresia is usually associated with a diminutive ascending aorta. The aortic arch may vary in length and diameter and occasionally is interrupted [3]. A variably sized coarctation ridge is present in the majority of cases due to ductal tissue which can extend and around the isthmus [4, 5].

The right ventricle supports the systemic circulation via a persistant ductus arteriosus PDA.

The left atrium tends to be smaller than normal and there is typically retrograde flow in the ascending aorta to the coronary arteries. Rarely, there is a restrictive foramen ovale or completely closed atrial septum. In the past, the diagnosis was made postnatally but currently in 40–85% [6] of cases HLHS is diagnosed antenatally between 18 and 22 weeks of gestation [7].

Pathophysiology
In the neonate born with HLHS the systemic circulation is dependent on ductal patency as well as a balance between pulmonary and systemic circulations. When pulmonary resistance falls, pulmonary blood flow can increase with rise in systemic oxygen saturation. This can lead to reduced systemic perfusion, metabolic acidosis, and ventricular failure. If pulmonary resistance increases and/or a restrictive foramen ovale is present, limiting pulmonary blood flow, hypoxia may develop. Therefore, initial medical support of patients with HLHS aims to maintain ductal patency and to provide a balanced flow between the systemic and pulmonary circulations. Continuous intravenous prostaglandin infusion (PGE2) is used to maintain ductal patency. Oxygen saturation is monitored and an acidotic metabolic state reversed. High inspired oxygen concentration may result in pulmonary vasodilatation, thus, the fraction of inspired oxygen (FIO2) needs to be adjusted to maintain relative hypoxemia (oxygen saturation 75–80%).

Management
In many countries in Europe, termination of pregnancy is seriously considered when an antenatal diagnosis of HLHS is made. A 71% termination rate after antenatal diagnosis has been reported in France [8] as compared to 35.3% in some areas of the UK [9]. If a diagnosis has not been made antenatally there are four options for treatment: (1) supportive therapy or ‘comfort care’ that will eventually lead to death. (2) Cardiac transplantation, however, there is an insufficient number of donor hearts available for neonates requiring transplantation and only a minority of patients are ever offered transplant. (3) Surgery for a three-stage palliative surgical approach. (4) Latterly, the introduction of a combined surgical and interventional catheter therapy – so called hybrid approach [10].

The three-stage surgical approach in Norwood procedure for palliation of hypoplastic left heart syndrome
The goal of the three-stage palliative approach is to use the right ventricle to support the systemic circulation. The first stage achieves this by connecting the right ventricle to the aorta whilst achieving balanced pulmonary blood flow through a systemic PA shunt. The second stage at 4–6 months of age removes the shunt and replaces it with a superior cavopulmonary connection and finally at about 4–6 years of age the inferior vena cava is connected to the pulmonary arteries to complete the Fontan circulation, creating separate pulmonary and systemic circulations supported by the single right ventricle.


    Surgical techniques
 Top
 Summary
 Introduction
 Surgical techniques
 Results
 Discussion
 Acknowledgements
 References
 
Stage I: Norwood procedure
The first stage palliation establishes unobstructed systemic and coronary blood flow from the right ventricle, unobstructed pulmonary venous return across the atrial septum and a balanced flow between the systemic and pulmonary circulations. The components of the first stage palliation consist of (a) anastomosis of the proximal pulmonary trunk to the aorta with homograft augmentation of the aortic arch, (b) atrial septectomy, and (c) establishment of a systemic to pulmonary shunt. The procedure was first described by William Norwood, who originally used a Blalock–Taussig shunt for blood supply to the pulmonary arteries ([11, 12] Schematic 1A). The procedure has since undergone a variety of modifications in terms of arch reconstruction and modification of blood supply for the pulmonary arteries. The latest modification consists of a right ventricular to pulmonary artery shunt introduced by Sano et al. [13] with the advantage of higher diastolic pressures to aid perfusion of coronary arteries. The RV-PA conduit has become an increasingly popular technique, taking the conduit to the left of the neo-aorta. At Birmingham Children's Hospital, we have modified the RV-PA conduit to route it to the right side of the neo-aorta.


Figure 1
View larger version (34K):
[in this window]
[in a new window]

 
Schematic 1 Different shunt techniques used for stage I Norwood procedure.

 
The patient is in a supine position; a central venous line is placed in the groin and an arterial line is placed preferentially in the right radial or brachial artery. The surgical approach is through a median sternotomy: the thymus is excised subtotally, the great vessels, their branches and the duct are all dissected free (Video 1), mobilized and encircled with silk ligatures, followed by heparinization.


Figure 1
Click on image to view video
Video 1 Dissection of great arteries and their branches and ductus arteriosus.
 
Arterial cannulation is effected by direct cannulation of the ascending aorta, if the aorta is of adequate size. Alternatively, if the aorta is <4 mm in diameter, the innominate artery is used for arterial access: the artery is dissected free superior to the innominate vein (Video 2), a side biting clamp placed and a 3-mm thin walled Gore-tex® tube [WL Gore & Associates (UK) Ltd., Livingston, Scotland] anastomosed using 8-0 Prolene (Video 3).


Figure 2
Click on image to view video
Video 2 If the aorta is <4 mm in diameter, the innominate artery is used for arterial access: the artery is dissected free superior to the innominate vein and a side biting clamp placed.
 

Figure 3
Click on image to view video
Video 3 Anastomosis of a 3-mm thin walled Gore-tex® tube using 8-0 prolene to the innominate artery.
 
An arterial line is advanced and secured within this tube. In case of a normal sized aorta, the latter may be cannulated directly and the tip of the cannula later advanced into the brachiocepahlic artery for antegrade cerebral perfusion during arch reconstruction. A single venous cannula is placed in the right atrial appendage, establishing cardiopulmonary bypass. Immediately after commencing bypass, the duct is ligated and the patient gradually cooled down to 18 °C at full flow. During cooling, and while the heart is still beating, the proximal pulmonary trunk is divided above the commissures of the pulmonary valve, leaving a vascular clamp on the proximal pulmonary trunk (Video 4).


Figure 4
Click on image to view video
Video 4 During cooling the proximal pulmonary trunk is divided above the commissures of the pulmonary valve, leaving a vascular clamp on the proximal pulmonary trunk.
 
The defect in the distal trunk proximal to the junction of the branch pulmonary arteries is either closed directly using a 7-0 prolene suture (Video 5) or, if the opening is close to the branch pulmonary arteries, a piece of thin walled Gore-tex® conduit may be used to patch this area.


Figure 5
Click on image to view video
Video 5 The defect in the distal trunk proximal to the junction of the branch pulmonary arteries is closed directly using a 7-0 prolene suture.
 
A thin walled Gore-tex® conduit is used for the right ventricular to pulmonary artery (RV-PA) conduit and is anastomosed to the anterior aspect of the right pulmonary artery (Schematic 1C, Video 6).


Figure 6
Click on image to view video
Video 6 A thin walled Gore-tex® conduit is used for the right ventricular to pulmonary artery (RV-PA) conduit and is anastomosed to the anterior aspect of the right pulmonary artery.
 
A 5-mm conduit is used for neonates ≥2.5 kg and a 4-mm conduit is used for neonates <2.5 kg. A short diagonal incision is made in the infundibulum of the right ventricle inferior to the pulmonary artery and the edges are undermined to create an unobstructed outflow. The Gore-tex® conduit is tailored in length and anastomosed to the incision, using 7-0 prolene (Video 7). This can be done on the beating heart if the aorta is atretic, otherwise the aorta is cross-clamped and cardioplegia given prior to this step to avoid any risk of air embolism. Having completed the anastomosis of the proximal RV-PA conduit, the circulation is arrested: all head vessels are occluded except the brachiocephalic artery which is occluded distal to the arterial line by snugging down the previously placed silk snares. A clamp is placed on the descending aorta distal to the coarctation ridge and the heart is arrested with cold crystalloid cardioplegia given through the side arm of the arterial cannula (30 ml/kg). The brachiocephalic artery is then snugged down, proximal to the arterial cannulation site.


Figure 7
Click on image to view video
Video 7 A short diagonal incision is made in the infundibulum of the right ventricle inferior to the pulmonary artery and the edges are undermined to create an unobstructed outflow. The Gore-tex® conduit is tailored in length and anastomosed to the incision, using 7-0 prolene.
 
The atrial cannula is removed and an atrial septectomy performed through the atrial cannulation site (Video 8). The atrial cannula is then placed back into the appendage of the right atrium and antegrade cerebral perfusion can be instituted at this point via the brachiocephalic artery at half flow (8 ml/kg/min).


Figure 8
Click on image to view video
Video 8 Having removed the atrial cannula an atrial septectomy is performed through the atrial cannulation site.
 
The duct is then divided at its junction with the descending aorta, the descending aorta further mobilized, preserving the recurrent laryngeal nerve, and all ductal tissue at the aorta excised (Video 9). The incision is extended distally into the descending aorta and proximally along the concavity of the aortic arch into the ascending aorta down below the level of the transected pulmonary arteries and into the aortic root (Video 10).


Figure 9
Click on image to view video
Video 9 The duct is then divided at its junction with the descending aorta, the descending aorta further mobilized, preserving the recurrent laryngeal nerve, and all ductal tissue at the aorta excised.
 

Figure 10
Click on image to view video
Video 10 The incision is extended distally into the descending aorta and proximally along the concavity of the aortic arch into the ascending aorta down below the level of the transected pulmonary arteries and into the aortic root.
 
If a prominent coarctation ridge is present this is resected and the posterior wall is reconstructed with 7-0 prolene (Video 11). However, if there is only a mild or no ridge then no resection is performed.


Figure 11
Click on image to view video
Video 11 If a prominent coarctation ridge is present this is resected and the posterior wall is reconstructed with 7-0 prolene.
 
The arch is then reconstructed with a patch of pulmonary homograft using continuous 7-0 prolene (Video 12). Before completion of this anastomosis, a separate incision is made into the homograft patch to receive the main pulmonary artery which is then anastomosed into this opening (Video 13) and the neoaortic reconstruction is completed (Video 14).


Figure 12
Click on image to view video
Video 12 The arch is then reconstructed with a patch of pulmonary homograft using continuous 7-0 prolene.
 

Figure 13
Click on image to view video
Video 13 A separate incision is made into the homograft patch to receive the main pulmonary artery which is then anastomosed into this opening.
 

Figure 14
Click on image to view video
Video 14 Completion of Damus–Kaye–Stansel (DKS) shunt.
 
After full rewarming the patient is weaned off bypass on Milrinone 0.5 µg/kg/min and adrenaline 0.05–0.2 µg/kg/min to maintain a mean blood pressure of 40–45 mmHg and a target arterial oxygen saturation of 70–80%. An on-table epicardial echocardiogram is used routinely to assess RV function, tricuspid valve regurgitation, RV-PA conduit flow, the atrial septectomy, and flow through the aortic arch. The chest is routinely left open with a chest drain and a peritoneal drain being placed and a fenestrated soft-tissue Gore-tex® patch is placed between the skin edges. The patient is transferred to the intensive care unit and remains fully paralyzed and sedated until the sternum is formally closed depending on haemodynamic stability after 48 h postoperatively; target arterial oxygen saturations are 70–80%, mean blood pressure 40–45 mmHg and mixed venous saturations are used to optimize cardiac output aiming for an arterio-venous difference of <30% [16]. Heparin is started within 12 h postoperatively with a rate of 10 IU/kg/h.

Stage II: superior cavopulmonary connection
Patients are followed-up initially with echo assessment with the intention of performing stage II at 4–6 months of age. Cardiac catheter is performed around 12–15 weeks after the initial operation to assess aortic arch repair and the pulmonary arteries. A degree of central pulmonary artery narrowing is a relatively common finding at stage II and may require patching at the time of surgery.

Stage II is performed at 4–6 months of age. In view of the relatively young age and the importance of obtaining optimal access to the pulmonary arteries we prefer to perform the stage II anastomosis under a period of deep hypothermic circulatory arrest. To perform a superior cavopulmonary connection, deep hypothermic cardiopulmonary bypass is established between the neoaortic arch and right atrium. The Gore-tex® shunt is divided between ligatures and the distal end excised. The proximal end is oversewn and left in situ. A stenosis of the pulmonary artery secondary to the prior shunt or patch is repaired using a patch of pulmonary homograft. The azygous vein is ligated. The SVC is divided at its junction with the right atrium and oversewn with 5-0 prolene, taking care to avoid the sinus node (Video 15). The SVC is anastomosed end-to-side to the superior aspect of the right pulmonary artery using continuous 6-0 polydioxane (PDS) sutures (Video 16). Thus, the calibre of the SVC, rather than the calibre of the right pulmonary artery defines the size of the anastomosis.


Figure 15
Click on image to view video
Video 15 The SVC is divided at its junction with the right atrium and oversewn with 5-0 prolene, taking care to avoid the sinus node.
 

Figure 16
Click on image to view video
Video 16 End-to-side anastomosis to the superior aspect of the right pulmonary artery using continuous 6-0 polydioxane (PDS) sutures.
 
Stage III: total cavopulmonary connection (TCPC)
Patients are assessed by cardiac catheterization approximately 24–36 months after the stage II procedure and the patient is managed similarly to any other patient going down the single ventricle pathway.

Our policy is not to have a fixed age for completing the Fontan circulation. Rather, the decision is based on findings at catheter and primarily, on clinical symptoms and degree of desaturation. This is generally at an age of 4–6 years. Significant narrowing of the branch pulmonary arteries – most commonly a degree of tubular hypoplasia of the left pulmonary artery – is treated with uncovered stent placement or with surgical patch reconstruction prior to stage III. Patients with a pulmonary artery pressure ≥15 mmHg or a transpulmonary gradient >7 mmHg are discussed on an individual basis and may undergo treatment for pulmonary vasodilatation prior to being reassessed. We prefer the extracardiac fenestrated conduit for stage III procedure TCPC. The procedure is performed at 32 °C on the beating heart using a size 18–22 mm Gore-tex® conduit from the inferior vena cava to the underside of the right pulmonary artery (Video 17). Any narrowing in the proximal left pulmonary artery can be addressed by bevelling the upper end of the conduit out to the left. A 5-mm fenestration is routinely created between the conduit and the facing right atrium using side biting clamps and 5-0 prolene sutures (Video 18). Both pleurae are routinely drained. Patients are heparinized following the procedure and converted to warfarin with a target INR at 2.0.


Figure 17
Click on image to view video
Video 17 Completion of cavopulmonary connection using a Gore-tex® conduit (size 18–22 mm) from the inferior vena cava to the right pulmonary artery.
 

Figure 18
Click on image to view video
Video 18 A 5 mm fenestration is routinely created between the conduit and the facing right atrium using side biting clamps and 5-0 prolene sutures.
 

    Results
 Top
 Summary
 Introduction
 Surgical techniques
 Results
 Discussion
 Acknowledgements
 References
 
The HLHS programme at Birmingham Children's Hospital begun in 1992 as the first in the UK. From October 1992 to December 2007, 445 patients presenting with true hypoplastic left heart syndrome or variants of that diagnosis underwent the Norwood stage I procedure; of these, 244 patients were treated with the ‘classical’ Norwood procedure (group A).

From April 2002, 201 patients were treated with an RV-PA conduit modification. The RV-PA was initially to the left side (n=28, group B), as described by Sano et al. [13], but from October 2003, this was changed to our own modification of the right-sided conduit (n=173, group C) as described above. Thirty-day mortality was 32.4% (79/244) in group A, 25.0% (7/28) in group B and 12.7% (22/173) in group C. Median cardiopulmonary bypass time was 66 min for the classical Norwood, 105 min for the left-sided conduits and 115 min for the right-sided conduits.

At the end of December 2007, 272 out of 445 patients had reached stage II, 25 patients were still in between stage I and II. The remaining 148 patients account for the interstage mortality in between stage I and stage II, which was 8.6% (21/244) for group A, 14.3% (4/28) for group B and 10.1% (15/148) for group C, thus, demonstrating a difference in techniques. Kaplan–Meier actuarial survival curves are shown in Graph 1.


Figure 1
View larger version (14K):
[in this window]
[in a new window]

 
Graph 1 Survival after the Norwood procedure for HLHS.

 
After stage II, 30-day mortality was 3.0% (10/335) for all groups, and 5.5% (8/145) in group A, 0% (0/76) in group B and 1.7% (2/114) in group C; interstage mortality in between stage II and stage III was 16.5% (24/145) for group A, 0% (0/12) for group B and 5.2% (6/114) for group C, including early death (30 days). We have an aggressive approach to pulmonary artery reconstruction and treat any reduction in diameter of ≥25% with patch enlargement at time of stage II surgery. Consequently, the incidence of central pulmonary patching has been 48.9% (42/145) in group A, 88.2% (15/17) in group B and 60.5% (69/114) in group C. The change in technique to the right-sided RV-PA conduit was developed to improve access to the central pulmonary arteries at the time of stage II. This led to decreased reconstruction time intraoperatively: medium cardiopulmonary bypass time for reconstruction of central pulmonary arteries was 43 min for the classical Norwood, 60 min for the left-sided conduits and 49 min for the right-sided conduits.

Stage III 30-day mortality was 0.9% (1/115) for all groups, and 1.0% (1/100) in group A, 0.0% (0/8) in group B and 0% (0/7) in group C and 1-year mortality after stage III was 5.1% (5/98) in group A, 0.0% (0/0) in group B and 0% (0/0) in group C (Table 1).


View this table:
[in this window]
[in a new window]

 
Table 1 Thirty-day mortality after stage I, II, and III

 

    Discussion
 Top
 Summary
 Introduction
 Surgical techniques
 Results
 Discussion
 Acknowledgements
 References
 
The Norwood procedure has revolutionized the management of HLHS and became one of the most challenging and dramatic developments in neonatal cardiac surgery over the past 25 years. The procedure has undergone a variety of developments and modifications over the years both in terms of surgical technique and in perioperative management and the outcomes have been characterized by a steady and remarkable improvement. Historically, a Blalock–Taussig shunt was the first choice of pulmonary blood flow as described by Norwood, and was later changed to a modified Blalock–Taussig shunt [10, 11]. However, there are disadvantages in using the modified Blalock–Taussig shunt with the Norwood procedure, because blood flows into the pulmonary arteries in both systole and diastole, thus, leading to a steal effect leading to inadequate pressure to supply the coronary arteries. The competing blood flow between the pulmonary and coronary arteries can result in sudden haemodynamic changes and instability after the operation. In 2003, Sano published his experience with a left RV-PA conduit which markedly improved hospital survival from 53% to 89% [13]. We reproduced these results in our institution [14]. The advantage of the Sano shunt as compared to the Blalock–Taussig shunt was the maintenance of a stable diastolic systemic pressure and no diastolic steal of coronary blood flow. That leads to improved early postoperative haemodynamics, however, it requires an incision on the right ventricle, with still unknown consequences concerning long-term ventricular function.

This technique has been quickly adopted at other centres, many of whom have reported an improvement of outcome. However, it has by no means been adopted universally and many experienced proponents of the classical technique continue to publish excellent results [15]. Both techniques are being applied currently in different centres, with a gradual improvement of postoperative outcome in every technique over the last years. This may in part be explained by better understanding of the physiology and perioperative management following either one of the techniques. At our institution, the Birmingham Children's Hospital, we gained experience with both techniques over a study period of 10 years (1997–2007), and have clearly identified an improvement in outcome after staged surgical management of HLHS, which was primarily attributable to changes in surgical technique [16]. The RV-PA conduit, in particular, was associated with a notable and independent improvement in early and actuarial survival [14]. However, others have found no difference in hospital survival when comparing both techniques [17] in a non-randomized study.

Sano originally described the anastomosis of the RV-PA shunt to the left pulmonary artery, but, the frequency and severity of central artery stenosis at the site of insertion in our patients led to our modification of the RV-PA conduit with anastomosis to the right pulmonary artery (Schematic 1C). We felt that mobilization of the left pulmonary artery as well as the neoaorta to access a stenosis seemed more complex and time consuming, while the right-sided RV-PA conduit offers the benefit of utilizing an anatomic site where the bidirectional Glenn shunt will be created later. Thus, our bypass and ischaemic times were reduced in patients that were treated with a right-sided shunt. Survival was better in patients with a right-sided shunt as compared with the left-sided shunt, although patients in both groups were similar in terms of preoperative patient characteristics, as well as operative time.

Use of a right-sided RV-PA conduit as opposed to the left-sided conduit in this cohort did lower the overall incidence of pulmonary stenoses; however, narrowing at the site of the anastomosis seems to be a constant problem and may be inherent to this technique. Despite the problem of central pulmonary artery stenosis there is evidence that the RV-PA conduit provides better growth of distal pulmonary arteries compared with the modified Blalock–Taussig shunt [18, 19], which may be related to more pulsatile flow.

The technique for repair of the coarctation we use was first described by Jonas et al. [20] based on the fact that most of the patients presented with coarctations that could not be dealt with by the technique originally described by Norwood, who created a neoaorta using the proximal pulmonary artery anastomosed to the ascending and proximal aortic arch [10]. We previously described a different technique, which was based on reconstruction of the neoaorta without patch supplementation [16]. However, this technique was more technically demanding, requiring several technical adjustments for each patient, and was abandoned in favour of the patch reconstruction described in this article. We believe that use of patch augmentation for the arch and ascending aorta, which we adopted in 1999, provides a more reproducible and easier surgical technique. Complete resection of the coarctation ridge leads to a higher rate of catheter based re-interventions, particularly on the left pulmonary artery [12]. This may be because the technique effectively lowers the height of the arch and reduces the volume of the concavity of the neoaortic arch, trapping the left pulmonary artery.

Improved outcomes in the Fontan circulation in HLHS have been characterized by the adoption of a staged approach and the use of the cavopulmonary shunt as an interim stage prior to the TCPC. This reduces the volume load on the systemic circulation resulting in lower systemic venous pressures [21] without increasing pulmonary blood flow too dramatically at this early age while also allowing for any necessary reconstruction of the central pulmonary arteries. The second important technical development has been the use of a fenestration in the Fontan circuit [22, 23]. Arterial oxygen saturation is lower, but cardiac output is higher and may even reduce severity and duration of postoperative pleural effusion and length of hospital stay [24] – although has not been consistently seen in all series. However, this has not been confirmed in our patients. It is our clinical practice to advise life-long anticoagulation with warfarin to reduce the risk of paradoxical embolism, to reduce the possible thrombus formation in the external conduit, and to minimize micro-thrombus formation that may lead to chronic pulmonary embolic events with gradual increase of pulmonary vascular resistance.

Over time there has been a significant improvement in outcome after reconstructive surgery due to refinements of surgical techniques and better understanding of perioperative physiology in HLHS. The three-stage Norwood procedure has become the mainstay for surgical management of HLHS.



    Acknowledgements
 Top
 Summary
 Introduction
 Surgical techniques
 Results
 Discussion
 Acknowledgements
 References
 
First and foremost we would like to thank the parents and patients and second we express our thanks to our colleagues and staff in theatres, on the paediatric intensive care unit, as well as on the ward.


    References
 Top
 Summary
 Introduction
 Surgical techniques
 Results
 Discussion
 Acknowledgements
 References
 

  1. Noonan JA, Nadas AS. The hypoplastic left heart syndrome; an analysis of 101 cases. Pediatr Clin North Am 1958;5:1029–1056.[Medline]
  2. Ferencz C, Rubin JD, McCarter RJ, Brenner JI, Neill CA, Perry LW, Hepner SI, Downing JW. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985;121:31–36.[Abstract/Free Full Text]
  3. Devloo-Blancquaert A, Titus JL, Edwards JE, Vallaeys JH, De Gezelle HR, Coppens M. Interruption of aortic arch and hypoplastic left heart syndrome. Pediatr Cardiol 1995;16:304–308.[CrossRef][Medline]
  4. Aiello VD, Ho SY, Anderson RH, Thiene G. Morphologic features of the hypoplastic left heart syndrome – a reappraisal. Pediatr Pathol 1990;10:931–943.[Medline]
  5. Anderson RH, Smith A, Cook AC. Hypoplasia of the left heart. Cardiol Young 2004;14:13–21.[CrossRef][Medline]
  6. Chew C, Halliday JL, Riley MM, Penny DJ. Population-based study of antenatal detection of congenital heart disease by ultrasound examination. Ultrasound Obstet Gynecol 2007;29:619–624.[CrossRef][Medline]
  7. Blake DM, Copel JA, Kleinman CS. Hypoplastic left heart syndrome: prenatal diagnosis, clinical profile, and management. Am J Obstet Gynecol 1991;165:529–534.[Medline]
  8. Sharland G, Rollings S, Simpson J, Anderson D. Hypoplastic left-heart syndrome. Lancet 2001;357:722.[Medline]
  9. Rasiah SV, Ewer AK, Miller P, Wright JG, Barron DJ, Brawn WJ, Kilby MD. Antenatal perspective of hypoplastic left heart syndrome: 5 years on. Arch Dis Child – Fetal Neonatal Ed 2008;93:F192–F197.[CrossRef][Medline]
  10. Akintuerk H, Michel-Behnke I, Valeske K, Mueller M, Thul J, Bauer J, Hagel KJ, Kreuder J, Vogt P, Schranz D. Stenting of the arterial duct and banding of the pulmonary arteries: basis for combined Norwood stage I and II repair in hypoplastic left heart. Circulation 2002;105:1099–1103.[Abstract/Free Full Text]
  11. Norwood WI, Lang P, Hansen DD. Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med 1983;308:23–26.[Medline]
  12. Norwood WI, Kirklin JK, Sanders SP. Hypoplastic left heart syndrome: experience with palliative surgery. Am J Cardiol 1980;45:87–91.[CrossRef][Medline]
  13. Sano S, Ishino K, Kawada M, Arai S, Kasahara S, Asai T, Masuda Z, Takeuchi M, Ohtsuki S. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2003;126:504–509; discussion 509–510.[Abstract/Free Full Text]
  14. Griselli M, McGuirk SP, Stümper O, Clarke AJB, Miller P, Dhillon R, Wright JGC, de Giovanni JV, Barron DJ, Brawn WJ. Influence of surgical strategies on outcome after the Norwood procedure. J Thorac Cardiovasc Surg 2006;131:418–426.[Abstract/Free Full Text]
  15. Tweddell JS, Hoffman GM, Mussatto KA, Fedderly RT, Berger S, Jaquiss RD, Ghanayem NS, Frisbee SJ, Litwin SB. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation 2002;106:I82–I89.[Medline]
  16. McGuirck SP, Griselli M, Stumper OF, Rumball EM, Miller P, Dhillon R, de Giovanni JV, Wright JG, Barron DJ, Brawn WJ. Staged surgical management of hypoplastic left heart syndrome: a single institution 12 year experience. Heart 2006;92:364–370.[Abstract/Free Full Text]
  17. Tabbutt S, Dominguez TE, Ravishankar C, Marino BS, Gruber PJ, Wernovsky G, Gaynor JW, Nicolson SC, Spray TL. Outcomes after the stage I reconstruction comparing the right ventricular to pulmonary artery conduit with the modified Blalock Taussig shunt. Ann Thorac Surg 2005;80:1582–1591.[Abstract/Free Full Text]
  18. Griselli M, McGuirck SP, Ofoe V, Stümper O, Wright JGC, de Giovanni JV, Barron DJ, Brawn WJ. Fate of pulmonary arteries following Norwood procedure. Eur J Cardiothorac Surg 2006;30:930–935.[Abstract/Free Full Text]
  19. Rumball EM, McGuirk SP, Stümper O, Laker SJ, de Giovanni JV, Wright JG, Barron DJ, Brawn WJ. The RV-PA conduit stimulates better growth of the pulmonary arteries in hypoplastic left heart syndrome. Eur J Cardiothorac Surg 2005;27:801–806.[Abstract/Free Full Text]
  20. Jonas RA, Lang P, Hansen D, Hickey P, Castaneda AR. First-stage palliation of hypoplastic left heart syndrome. The importance of coarctation and shunt size. J Thorac Cardiovasc Surg 1986;92:6–13.[Abstract]
  21. Bridges ND, Mayer JE Jr, Lock JE, Jonas RA, Hanley FL, Keane JF, Perry SB, Castaneda AR. Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation 1992;86:1762–1769.[Abstract/Free Full Text]
  22. Norwood WI, Jacobs ML. Fontan's procedure in two stages. Am J Surg 1993;166:548–551.[CrossRef][Medline]
  23. Gentles TL, Mayer JE Jr, Gauvreau K, Newburger JW, Lock JE, Kupferschmid JP, Burnett J, Jonas RA, Castañeda AR, Wernovsky G. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg 1997;114:376–391.[Abstract/Free Full Text]
  24. Lemler MS, Scott WA, Leonard SR, Stromberg D, Ramaciotti C. Fenestration improves clinical outcome of the Fontan procedure. A prospective, randomized study. Circulation 2002;105:207–212.[Abstract/Free Full Text]




This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Podcast
Right arrow Alert me when this content is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this publication
Right arrow Alert me when new content is published
Right arrow Download to citation manager
Right arrow Author home page(s):
Alexander M. Fabricius
Timothy J. Jones
John G. Wright
David J. Barron
William J. Brawn
Right arrow Alert me when related articles are published
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fabricius, A. M.
Right arrow Articles by Brawn, W. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fabricius, A. M.
Right arrow Articles by Brawn, W. J.
Related Collections
Right arrow Single ventricle


HOME HELP FEEDBACK SUBSCRIPTIONS SEARCH